Search Results
Oct 07, 2025, 09:00 ET CAZ Investments Commits $400 Million to Bonaccord Capital Partners
our strong belief in the GP stakes strategy. Bonaccord's expertise in identifying and partnering with top-tier, middle-market private asset managers aligns with our strategic vision." This investment underscores CAZ Investments' prominent role in the GP Stakes ecosystem, to which
More news about: CAZ Investments
Oct 07, 2025, 08:00 ET Blue Owl Capital Inc. to Announce Third Quarter 2025 Results
With over $284 billion in assets under management as of June 30, 2025, we invest across three multi-strategy platforms: Credit, Real Assets, and GP Strategic Capital. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer
More news about: Blue Owl Capital
Oct 06, 2025, 12:03 ET Hyundai Wins 'Platinum' in 2025 Pinnacle Awards for Purpose-Driven Marketing
inquiry-based activity that teaches STEM concepts while encouraging teamwork and critical thinking. Additionally, Hyundai expanded its partnership with the H2GP Foundation for the Hyundai RC program, sponsoring student teams for the Georgia Hydrogen Grand Prix, where they built and raced hydrogen-powered RC cars,
More news about: Hyundai Motor America
Oct 06, 2025, 09:00 ET California ISEF Incentive Program Reopens on October 21st GreenPower's EV Stars are Eligible for up to $130,000 of Incentives
GreenPower Motor Company Inc. (Nasdaq: GP) (TSXV: GPV) ("GreenPower"), a leading manufacturer and distributor of all-electric, purpose-built, zero-emission medium and heavy-duty vehicles serving
More news about: GreenPower Motor Company
Oct 03, 2025, 09:35 ET Announcing Wave Function Ventures' $15M Fund I to Back Deep Tech Founders
building hardware solutions to the world's most important problems. Wave Function Ventures was started by industry veteran and solo GP
More news about: Wave Function Ventures
Oct 02, 2025, 08:56 ET Martus Scales Channel to 89 Partners and Record-Breaking 91% ARR as Finance Automation Accelerates
operations. eXponential Consulting – Scaling organizations with Sage Intacct and Microsoft Dynamics GP. Han Group – ERP and digital transformation, with accounting and advisory for
More news about: Martus Solutions
Sep 30, 2025, 08:32 ET Recast Capital Announces Third Cohort for Accelerate Program to Drive the Next Generation of Venture Capital
and capital in support of each fund's backend operations. The Fall 2025 cohort welcomes GPs from 18 funds; 28% have at least one GP who is Black, 17% Asian, 11% LatinX, 6% LGBTQ, and 28% first generation US citizens. The participating funds are headquartered across the US, and over
More news about: Recast Capital
Sep 30, 2025, 05:00 ET EF Polymer Completes Series B Second Close
Corporation / Melissa Estate International Co., Ltd. / OLtV Opportunity Fund / Soken Chemical & Engineering Co., Ltd. / SVG Ventures Sunrise Agri Fund GP, LLC / Okinawa Development Finance Corporation / TOPPAN Holdings Inc. / Toyoda Gosei Co., Ltd. Narayan Lal
More news about: EF Polymer K.K.
Sep 30, 2025, 05:00 ET EF Polymer Completes Series B Second Close
Corporation / Melissa Estate International Co., Ltd. / OLtV Opportunity Fund / Soken Chemical & Engineering Co., Ltd. / SVG Ventures Sunrise Agri Fund GP, LLC / Okinawa Development Finance Corporation / TOPPAN Holdings Inc. / Toyoda Gosei Co., Ltd. Narayan Lal
More news about: EF Polymer K.K.
Sep 29, 2025, 09:00 ET All-electric school bus pilot gearing up in New Mexico
GreenPower (NASDAQ: GP) (TSXV: GPV), a leading manufacturer and distributor of all-electric, purpose-built, zero-emission medium and heavy-duty vehicles serving the cargo and
More news about: GreenPower Motor Company
Sep 29, 2025, 08:52 ET Health Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences
entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gilead") for encequidar, a first-in-class P-glycoprotein ("P-gp") inhibitor in the field of virology.
More news about: Health Hope Pharma
Sep 29, 2025, 08:42 ET Two Seas Capital Files Definitive Proxy Statement and Issues Letter to Core Scientific Shareholders Urging Them to Vote AGAINST Company's Proposed Sale to CoreWeave
Important Information Two Seas, Two Seas Capital GP LLC ("Two Seas GP"), and Sina Toussi ("Mr. Toussi" and, together with Two Seas and Two Seas GP, the "Participants") have filed a definitive proxy statement and accompanying GOLD proxy card (the "Proxy
More news about: Two Seas Capital
Sep 29, 2025, 08:41 ET Health Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences
entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gilead") for encequidar, a first-in-class P-glycoprotein ("P-gp") inhibitor in the field of virology.
More news about: Health Hope Pharma
Sep 29, 2025, 08:31 ET 希華醫藥與吉利德簽署獨家授權協議
2025年9月29日 /美通社/ -- 希華醫藥有限公司（「希華」）今天宣布，它已與吉利德科學公司（「吉利德」）就首創 P-糖蛋白 (「P-gp」) 抑制劑 encequidar 達成病毒學領域方面的全球授權和合作協議。
More news about: Health Hope Pharma
Sep 29, 2025, 06:14 ET Hanmi's Oral Delivery Platform Compound Licensed to Gilead
oral drug delivery proprietary platform owned by Hanmi that enables the conversion of injectable medicines into oral formulations. Encequidar is a P-gp inhibitor that was discovered through Hanmi's Orascovery™ platform and originally developed by Hanmi. Under this agreement, Hanmi
More news about: Hanmi Pharm
Sep 29, 2025, 05:45 ET Hanmi's Oral Delivery Platform Compound Licensed to Gilead
oral drug delivery proprietary platform owned by Hanmi that enables the conversion of injectable medicines into oral formulations. Encequidar is a P-gp inhibitor that was discovered through Hanmi's Orascovery™ platform and originally developed by Hanmi. Under this agreement, Hanmi
More news about: Hanmi Pharm
Sep 26, 2025, 07:30 ET Camac Fund and DJA Partners Nominate Five Independent Directors to Urgently Unlock Shareholder Value at CreateAI Holdings
said Eric Shahinian and Daniel Abrams, Managing Members of Camac Fund and DJA Partners GP, respectively. Contacting the Nominating StockholdersEric Shahinian –
More news about: Camac Partners, LLC
Sep 25, 2025, 14:01 ET U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
use cannot be avoided, increase the dosage of Inluriyo. Imlunestrant inhibits both P-gp and BCRP. Avoid concomitant use unless otherwise recommended in the Prescribing Information for P-gp or BCRP substrates where minimal concentration changes may lead to serious adverse reactions.
More news about: Eli Lilly and Company
Sep 25, 2025, 12:49 ET Burnt Raises $3.8M in Seed Funding to Accelerate Food Supply Chain
many headaches and low efficiency workflows that result in massive opportunity costs," said Elizabeth Weil, Founder & GP at Scribble Ventures. "Given their deep industry knowledge, the Burnt founders are the right team to build an AI solution that gives time back to the
More news about: Burnt
Sep 25, 2025, 07:00 ET Qatar Investment Authority and Blue Owl Capital Enter Agreement to Establish Digital Infrastructure Partnership
in assets under management as of June 30, 2025, we invest across three multi-strategy platforms: Credit, Real Assets and GP Strategic Capital. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer
More news about: Blue Owl Capital
Sep 25, 2025, 07:00 ET Qatar Investment Authority and Blue Owl Capital Enter Agreement to Establish Digital Infrastructure Partnership
in assets under management as of June 30, 2025, we invest across three multi-strategy platforms: Credit, Real Assets and GP Strategic Capital. Anchored by a strong permanent capital base, we provide businesses with private capital solutions to drive long-term growth and offer
More news about: Blue Owl Capital
Sep 25, 2025, 07:00 ET Die Qatar Investment Authority und Blue Owl Capital schließen eine Vereinbarung zur Gründung einer Partnerschaft für digitale Infrastruktur
verwalteten Vermögen von über 284 Milliarden US-Dollar (Stand: 30. Juni 2025) investieren wir über drei Multi-Strategie-Plattformen: Kredit, Real Assets und GP Strategic Capital. Gestützt auf eine starke permanente Kapitalbasis stellen wir Unternehmen private Kapitallösungen zur Verfügung, um langfristiges Wachstum
More news about: Blue Owl Capital
Sep 25, 2025, 07:00 ET QIA y Blue Owl firman un acuerdo para establecer una asociación de infraestructura digital
dólares en activos bajo gestión a 30 de junio de 2025, invertimos en tres plataformas multiestrategia: Crédito, Activos Reales y Capital Estratégico GP. Con una sólida base de capital permanente, ofrecemos a las empresas soluciones de capital privado para impulsar el crecimiento a largo plazo y ofrecemos
More news about: Blue Owl Capital
Sep 25, 2025, 07:00 ET Le fonds Qatar Investment Authority et Blue Owl Capital concluent un accord en vue d'établir un partenariat dans le domaine de l'infrastructure numérique
d'actifs sous gestion au 30 juin 2025, nous investissons à travers trois plateformes multistratégiques : Crédit, Actifs réels et Capital stratégique GP. En nous appuyant sur une base de capital permanent solide, nous offrons aux entreprises des solutions de capital privé pour stimuler la croissance à
More news about: Blue Owl Capital
Sep 25, 2025, 06:00 ET Tungray Technologies Inc Announces Results of 2025 Annual General Meeting of Shareholders
the next Annual General Meeting or until their successors are duly elected and qualified;Ratified the appointment of Guangdong Prouden CPAs GP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025; andApproved
More news about: Tungray Technologies Inc